The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples